case study
TRANSCRIPT
© 2014 CeleroCSConfidential Information
Accelerating Resultswww.celerocommercialsolutions.comCelero
The situation
• Customer entering new therapeutic market
• Board of Directors wants to understand payer landscape to drill into financial projections
• Customer purchased IMS payer data for proxy product
• IMS and customer unable to combine and analyze >200,000 records into Board-ready results
2
© 2014 CeleroCSConfidential Information
Accelerating Resultswww.celerocommercialsolutions.comCelero
Celero Approach• Understanding the data
– Given Celero’s deep knowledge of Life Science and the data supporting it, Celero was able to quickly understand the data set and determine an approach to aggregate
• Preparing the data– Data volume, although not too large, still exceeding what Excel could easily
manipulate– Celero’s partnerships with leading edge data analytics companies – in this case,
Paxata – enable rapid consumption of the data set with no overhead– Paxata facilitated aggregation of payer data through its unique “cluster and edit”
functionality– Additional consolidation of payer records was completed via 3rd party source of
payer affiliations
3
© 2014 CeleroCSConfidential Information
Accelerating Resultswww.celerocommercialsolutions.comCelero
Results
• Payers were ranked based upon volume of prior sales
• Board-ready data table and graphics generated in less than 8 hours from time of data receipt by Celero
• >220,000 data points turned into ~900 customer records for actionable account planning & forecasting
4
© 2014 CeleroCSConfidential Information
Accelerating Resultswww.celerocommercialsolutions.comCelero
The Journey
5
Guided “Cluster & Edit” facilitatesaggregation while maintaining audit
trail of changes.
© 2014 CeleroCSConfidential Information
Accelerating Resultswww.celerocommercialsolutions.comCelero
The Journey
6
Guided “Cluster & Edit” facilitatesaggregation while maintaining audit
trail of changes.